Wei Lingxin, Deng Xiaoming, Sui Jinghu, Wang Lei, Liu Juhui
From the Department of Anesthesiology, Plastic Surgery Hospital, Peking Union Medical College, Beijing, China.
Anesth Analg. 2015 Sep;121(3):785-790. doi: 10.1213/ANE.0000000000000812.
Anesthesia induction using propofol (3 mg/kg) and remifentanil (2 μg/kg) without the use of muscle relaxants has been associated with a lower incidence of successful intubation. Dexmedetomidine has been found to effectively decrease the requirements for propofol and remifentanil and to attenuate the hemodynamic response to intubation. Therefore, in this study, we examined intubating conditions and hemodynamic changes in children after induction with dexmedetomidine (1 μg/kg) combined with propofol (3 mg/kg) and remifentanil (2 μg/kg).
This randomized, double-blinded, and placebo-controlled study included 60 ASA physical status I children aged 5 to 10 years. The children were randomly allocated to a dexmedetomidine group (group D) or a placebo group (group P). After IV administration of atropine (0.01 mg/kg), anesthesia was induced with an infusion of dexmedetomidine (1 μg/kg) over 2 minutes for group D, whereas normal saline was infused for group P. Propofol (3 mg/kg) was then injected IV over 20 to 30 seconds, followed by an infusion of remifentanil (2 μg/kg) over 1 minute for both groups. One minute later, laryngoscopy and tracheal intubation were performed.
For group D and group P, tracheal intubation was successful in 90% (27/30) and 53% (16/30) of patients (P = 0.0034), respectively. Excellent conditions were present in 22 of 27 and 8 of 16 of intubations, respectively, resulting in an overall incidence of excellent conditions of 73% (22/30) and 27% (8/30), respectively (P = 0.0007). Systolic blood pressure significantly increased after the IV injection of dexmedetomidine compared with baseline readings (P = 0.012, with a confidence interval of 2-22 mm Hg).
A single dose of dexmedetomidine (1 μg/kg) improved intubation conditions in children after induction with propofol (3 mg/kg) and remifentanil (2 μg/kg) without muscle relaxants. Dexmedetomidine did not affect the hemodynamic response to intubation.
使用丙泊酚(3mg/kg)和瑞芬太尼(2μg/kg)进行麻醉诱导且不使用肌肉松弛剂与较低的插管成功率相关。已发现右美托咪定可有效降低丙泊酚和瑞芬太尼的用量,并减轻插管时的血流动力学反应。因此,在本研究中,我们观察了右美托咪定(1μg/kg)联合丙泊酚(3mg/kg)和瑞芬太尼(2μg/kg)诱导后儿童的插管条件和血流动力学变化。
本随机、双盲、安慰剂对照研究纳入了60例年龄在5至10岁的ASA身体状况I级儿童。这些儿童被随机分配至右美托咪定组(D组)或安慰剂组(P组)。静脉注射阿托品(0.01mg/kg)后,D组在2分钟内静脉输注右美托咪定(1μg/kg)诱导麻醉,而P组输注生理盐水。然后两组均在20至30秒内静脉注射丙泊酚(3mg/kg),随后在1分钟内静脉输注瑞芬太尼(2μg/kg)。1分钟后,进行喉镜检查和气管插管。
D组和P组患者的气管插管成功率分别为90%(27/30)和53%(16/30)(P = 0.0034)。插管情况良好的分别为27例中的22例和16例中的8例,总体良好率分别为73%(22/30)和27%(8/30)(P = 0.0007)。与基线读数相比,静脉注射右美托咪定后收缩压显著升高(P = 0.012,置信区间为2 - 22mmHg)。
单剂量右美托咪定(1μg/kg)可改善丙泊酚(3mg/kg)和瑞芬太尼(2μg/kg)诱导且不使用肌肉松弛剂的儿童的插管条件。右美托咪定不影响插管时的血流动力学反应。